Lara Lavelle-Langham
University of London(GB)University of Liverpool(GB)Aintree University Hospitals NHS Foundation Trust(GB)London School of Hygiene & Tropical Medicine(GB)Imperial College London(GB)
Publications by Year
Research Areas
Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, Intensive Care Unit Cognitive Disorders
Most-Cited Works
- → Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial(2022)77 cited
- → Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial(2022)42 cited
- → Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection(2022)19 cited
- → Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK(2021)19 cited
- → Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury(2023)11 cited
- → A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2